These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8547205)

  • 21. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
    Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias.
    Naito H; Furukawa Y; Chino D; Yamada C; Hashimoto K
    Eur J Pharmacol; 2000 Jan; 388(2):171-6. PubMed ID: 10666509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facilitation of reentry by lidocaine in canine myocardial infarction.
    Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
    Am Heart J; 1994 Feb; 127(2):345-52. PubMed ID: 7507635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block.
    Boucher M; Chapuy E; Lefebvre MA; Mignot A; Duchêne-Marullaz P
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):630-7. PubMed ID: 2570365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
    Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of verapamil against ventricular arrhythmias induced by programmed electrical stimulation in the late myocardial infarction phase in dogs.
    Krejcy K; Krumpl G; Todt H; Raberger G
    J Pharm Pharmacol; 1992 Apr; 44(4):349-54. PubMed ID: 1355549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-Dependent Effects of Ranolazine on Reentrant Ventricular Arrhythmias Induced After Subacute Myocardial Infarction in Rabbits.
    Moschovidis V; Simopoulos V; Stravela S; Dipla K; Hatziefthimiou A; Stamatiou R; Aidonidis I
    J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):65-71. PubMed ID: 31242756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Zeneca ZD7288 in comparison with alinidine and UL-FS 49 on guinea pig sinoatrial node and ventricular action potentials.
    Briggs I; BoSmith RE; Heapy CG
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):380-7. PubMed ID: 7528293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
    Black SC; Chi LG; Mu DX; Lucchesi BR
    J Pharmacol Exp Ther; 1991 Aug; 258(2):416-23. PubMed ID: 1865349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological mechanisms of action of the levorotatory isomer of sotalol in a canine infarct model of inducible ventricular tachycardia: comparison with the beta-1 receptor antagonist bisoprolol.
    Aidonidis I; Rizos I; Hilbel T; Kuebler W; Brachmann J
    J Mol Cell Cardiol; 1994 Jul; 26(7):841-8. PubMed ID: 7966352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs.
    Chézalviel F; Weissenburger J; Guhennec C; Jagueux M; Davy JM; Vernhet L; Simandoux V; Poirier JM; Cheymol G
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):212-20. PubMed ID: 7679154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of AHR-12234 on cardiac transmembrane action potentials, in situ cardiac electrophysiology and experimental models for arrhythmias.
    Wu KM; Proakis AG; Hunter TL; Shanklin JR
    Arch Int Pharmacodyn Ther; 1989; 301():131-50. PubMed ID: 2624512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction.
    Lynch JJ; Uprichard AC; Frye JW; Driscoll EM; Kitzen JM; Lucchesi BR
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):585-97. PubMed ID: 2478772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic and electrophysiologic effects of ontazolast in dogs.
    Hamlin RL; Nakayama T; Brady JT; Stoll RE
    Am J Vet Res; 2000 Nov; 61(11):1364-8. PubMed ID: 11108180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
    Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
    J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
    Friedrichs GS; Abreu JN; Driscoll EM; Borlak J; Lucchesi BR
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):56-66. PubMed ID: 9456278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of zatebradine on ouabain-, two-stage coronary ligation- and epinephrine-induced ventricular tachyarrhythmias.
    Furukawa Y; Xue YX; Chiba S; Hashimoto K
    Eur J Pharmacol; 1996 Apr; 300(3):203-10. PubMed ID: 8739209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proarrhythmic effects of procainamide and tocainide in a canine infarction model.
    Steinberg JS; Sahar DI; Rosenbaum M; Cook JR; Bigger JT
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):52-9. PubMed ID: 1375688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of alinidine, a specific bradycardic agent, to dobutamine in a canine model of endotoxic shock.
    Preiser JC; Moulart D; Vincent JL
    Crit Care Med; 1992 Aug; 20(8):1146-51. PubMed ID: 1643894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.